Cargando…

Androgen Receptor and PI3K Pathway Activity in Ovarian Cancer

We sought to evaluate androgen receptor (AR) and PI3K pathway activity in ovarian cancer cell lines and tissue and determine if either pathway was correlated with growth of ovarian cancers. AR expression and activity were quantified using immunohistochemistry (IHC) and RT-qPCR in six ovarian cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hill, Addie, Cristea, Mihaela, He, Miaoling, Frankel, Paul, Neuhausen, Susan, Pal, Sumanta K, Jones, Jeremy O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682960/ https://www.ncbi.nlm.nih.gov/pubmed/34926721 http://dx.doi.org/10.17303/jcrto.2019.7.103

Ejemplares similares

Vitamin K epoxide reductase regulation of androgen receptor activity
por: Tew, Ben Yi, et al.
Publicado: (2017)

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium
por: Pal, Sumanta K., et al.
Publicado: (2019)

Factors that influence the androgen receptor cistrome in benign and malignant prostate cells
por: Copeland, Ben T., et al.
Publicado: (2019)

MicroRNA-195 suppresses rectal cancer growth and metastasis via regulation of the PI3K/AKT signaling pathway
por: Wang, Yeli, et al.
Publicado: (2019)

PI3K-AKT-mTOR Pathway is Dominant over Androgen Receptor Signaling in Prostate Cancer Cells
por: Kaarbø, Mari, et al.
Publicado: (2010)

Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways
por: Lu, Xinxing, et al.
Publicado: (2020)

Testosterone Promotes the Proliferation of Chicken Embryonic Myoblasts Via Androgen Receptor Mediated PI3K/Akt Signaling Pathway
por: Li, Dongfeng, et al.
Publicado: (2020)

Targeting EGFR and PI3K pathways in ovarian cancer
por: Glaysher, S, et al.
Publicado: (2013)

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
por: Lehmann, Brian D, et al.
Publicado: (2014)

Osteopontin-c mediates the upregulation of androgen responsive genes in LNCaP cells through PI3K/Akt and androgen receptor signaling
por: TILLI, TATIANA MARTINS, et al.
Publicado: (2015)

Genomic mutation-driven metastatic breast cancer therapy: a single center experience
por: Yuan, Yuan, et al.
Publicado: (2017)

The Role of Androgen Receptor Signaling in Ovarian Cancer
por: Mizushima, Taichi, et al.
Publicado: (2019)

Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials
por: Chung, Wei-Min, et al.
Publicado: (2021)

The role of peroxisome proliferator-activated receptor gamma in prostate cancer
por: Elix, Catherine, et al.
Publicado: (2018)

Complex Impacts of PI3K/AKT Inhibitors to Androgen Receptor Gene Expression in Prostate Cancer Cells
por: Liu, Liangliang, et al.
Publicado: (2014)

Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience
por: Yuan, Yuan, et al.
Publicado: (2017)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
por: Dobbin, Zachary C., et al.
Publicado: (2013)

Bicalutamide, an androgen receptor antagonist, effectively alleviate allergic rhinitis via suppression of PI3K–PKB activity
por: Zhang, Yu, et al.
Publicado: (2022)

Correction: Androgen Receptor CAG Repeats Length Polymorphism and the Risk of Polycystic Ovarian Syndrome (PCOS)
por: Rajender, Singh, et al.
Publicado: (2013)

Zebrafish androgen receptor is required for spermatogenesis and maintenance of ovarian function
por: Yu, Guangqing, et al.
Publicado: (2018)

Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer
por: Qi, Wenqing, et al.
Publicado: (2015)

Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond
por: Chan, Jack J., et al.
Publicado: (2019)

Androgen Plays a Carcinogenic Role in EOC via the PI3K/AKT Signaling Pathway in an AR-Dependent Manner
por: Li, Yanfang, et al.
Publicado: (2021)

Identification of neuron selective androgen receptor inhibitors
por: Otto-Duessel, Maya, et al.
Publicado: (2017)

The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
por: Cheaib, Bianca, et al.
Publicado: (2015)

Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K/AKT signaling pathway in LNCaP prostate cancer cells
por: Ye, Mushi, et al.
Publicado: (2020)

A study of the decay modes $K^{\pm} \rightarrow \pi^{\pm} \pi^{0} \pi^{0}$ and $K^{\pm} \rightarrow \pi^{\pm} \pi^{0} \gamma$
por: Smith, K M, et al.
Publicado: (1971)

The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women
por: Hu, Qiaofei, et al.
Publicado: (2017)

The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications
por: Zhu, Haiyan, et al.
Publicado: (2016)

Androgen receptor status predicts development of brain metastases in ovarian cancers
por: Mittica, Gloria, et al.
Publicado: (2017)

Role of Androgen Receptor for Reconsidering the “True” Polycystic Ovarian Morphology in PCOS
por: Gao, Xue-ying, et al.
Publicado: (2020)

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
por: Kasparian, Saro, et al.
Publicado: (2023)

LOW-INTENSITY EXERCISE ENHANCES MUSCULAR ANDROGEN/ANDROGEN RECEPTOR TO INHIBIT MYOSTATIN PATHWAY
por: Son, Bo-Kyung, et al.
Publicado: (2019)

PI3K Pathway in NSCLC
por: Martinez-Martí, Alex, et al.
Publicado: (2012)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
por: Aziz, Aziz Ur Rehman, et al.
Publicado: (2018)

PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
por: Gasparri, Maria Luisa, et al.
Publicado: (2017)

CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy
por: Salgado-Albarrán, Marisol, et al.
Publicado: (2022)

Crucial role of androgen receptor in resistance and endurance trainings-induced muscle hypertrophy through IGF-1/IGF-1R- PI3K/Akt- mTOR pathway
por: YIN, Lijun, et al.
Publicado: (2020)

PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition
por: Triscott, Joanna, et al.
Publicado: (2023)

Selection Study for B+- -> (K-+ pi+- pi-+ pi+-)D K+- and B+- -> (K+ K- pi+ pi-)D K+-".
por: Hunt, P, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r7hjlpaivvj28uodgafqejc8qc